← back to search

Keith Van Haren

Stanford University · US
Area of research
Molecular Biology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Peroxisome Proliferator-Activated Receptors, Viral Infections and Immunology Research, Metabolism and Genetic Disorders, and RNA regulation and disease.
h-index
28
citations
3,777
works
92
NIH funding
primary concept
email

Recent publications

Influenza-Associated Acute Necrotizing Encephalopathy in US Children
JAMA 2025cited by 15position: middledoi
Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study
Annals of the Child Neurology Society 2025cited by 0position: middledoi
Consensus guidelines for the monitoring and management of metachromatic leukodystrophy in the United States
Cytotherapy 2024cited by 24position: middledoi
Longitudinal natural history studies based on real-world data in rare diseases: Opportunity and a novel approach
Molecular Genetics and Metabolism 2024cited by 21position: middledoi
Immunotherapy in Autoimmune Encephalitis
Neurology 2023cited by 8position: lastdoi
Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy
Annals of the Child Neurology Society 2023cited by 2position: firstdoi
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy
Neurology 2022cited by 136position: middledoi
A phase I study of oral vitamin D3 in boys with X-linked adrenoleukodystrophy
medRxiv 2022cited by 1position: firstdoi
Vitamin D Status & Latitude Predict Brain Lesions in Adrenoleukodystrophy
medRxiv 2021cited by 0position: firstdoi
Acute flaccid myelitis: cause, diagnosis, and management
The Lancet 2020cited by 177position: middledoi
Genetic and phenotypic spectrum associated with IFIH1 gain‐of‐function
Human Mutation 2020cited by 111position: middledoi
<scp>MRI</scp> surveillance of boys with X‐linked adrenoleukodystrophy identified by newborn screening: Meta‐analysis and consensus guidelines
Journal of Inherited Metabolic Disease 2020cited by 80position: middledoi
Randomized Clinical Trial of<scp>First‐Line</scp>Genome Sequencing in Pediatric White Matter Disorders
Annals of Neurology 2020cited by 28position: middledoi
Allogeneic HSCT for adult-onset leukoencephalopathy with spheroids and pigmented glia
Brain 2019cited by 61position: middledoi
Consensus Guidelines: MRI Surveillance of Children with Presymptomatic Adrenoleukodystrophy (P4.6-047)
Neurology 2019cited by 3position: middledoi
Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis
Neurology 2018cited by 69position: middledoi
1901. Safety, Tolerability, and Efficacy of Fluoxetine as an Antiviral for Enterovirus D68 Associated Acute Flaccid Myelitis: A Retrospective Multicenter Cohort Study
Open Forum Infectious Diseases 2018cited by 1position: middledoi
Revised consensus statement on the preventive and symptomatic care of patients with leukodystrophies
Molecular Genetics and Metabolism 2017cited by 73position: middledoi
Pediatric Bickerstaff brainstem encephalitis: a systematic review of literature and case series
Journal of Neurology 2017cited by 28position: lastdoi
Acute flaccid myelitis: A clinical review of US cases 2012–2015
Annals of Neurology 2016cited by 221position: middledoi
A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study
The Lancet Infectious Diseases 2015cited by 399position: middledoi
Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015
JAMA 2015cited by 134position: firstdoi
Disease specific therapies in leukodystrophies and leukoencephalopathies
Molecular Genetics and Metabolism 2015cited by 55position: middledoi
ALD Connect: A Patient Powered Research Network harmonizes efforts to cure Adrenoleukodystrophy (P4.054)
Neurology 2015cited by 0position: firstdoi
Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014.
PubMed 2014cited by 106position: middle
Consensus statement on preventive and symptomatic care of leukodystrophy patients
Molecular Genetics and Metabolism 2014cited by 47position: firstdoi
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing– remitting multiple sclerosis
Multiple Sclerosis Journal 2013cited by 55position: firstdoi
National Variation in Costs and Mortality for Leukodystrophy Patients in US Children's Hospitals
Pediatric Neurology 2013cited by 37position: middledoi
Identification of Naturally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
Science Translational Medicine 2012cited by 65position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Joshua L. Bonkowsky · Intermountain Healthcare7 papers (2013–2024)Gerald V. Raymond · Johns Hopkins Hospital6 papers (2015–2023)Adeline Vanderver · University of Colorado Denver5 papers (2014–2024)Florian Eichler · Harvard University5 papers (2015–2024)Carol Glaser · California Department of Public Health4 papers (2014–2016)Ali Fatemi · Kennedy Krieger Institute4 papers (2015–2024)Ann B. Moser · Kennedy Krieger Institute4 papers (2019–2023)Kevin Messacar · Children's Hospital Colorado3 papers (2015–2018)Lawrence Steinman · Stanford University3 papers (2012–2022)Amy Pizzino · George Washington University3 papers (2014–2024) · 3 papers (2014–2015)Jacob Wilkes · Intermountain Healthcare3 papers (2013–2023)Samuel R. Dominguez · Children's Hospital Colorado3 papers (2015–2018) · 3 papers (2014–2015)Emmanuelle Waubant · University of California, San Francisco3 papers (2014–2022) · 3 papers (2014–2015) · 2 papers (2014–2015)Bela R. Turk · Kennedy Krieger Institute2 papers (2019–2020)Guy Helman · Hospital for Sick Children2 papers (2014–2015)Timothy W. Collins · University of Utah2 papers (2021–2023)